ConductScience.org, home

Paper21990299

Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.

Yang D and 6 others. JAMA, 2011. Cited by 476 papers, by iCite.

Cite this record

ConductScience Library. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. Papers, record 21990299. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21990299

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.
PubMed
Journal
JAMA
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
476
iCite
Relative citation ratio, by iCite
10.9
iCite
Revised in PubMed
2024-12-19
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang DDa
2Khan SSofia
3Sun YYan
4Hess KKenneth
5Shmulevich IIlya
6Sood AKAnil K
7Zhang WWei

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genes, BRCA1Major topic
Genes, BRCA2Major topic
MutationMajor topic
Ovarian NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
DNA Methylation
Databases, Factual
Disease Progression
Drug Resistance, Neoplasm
Female
Genomic Instability
Humans
Middle Aged
Phenotype
Prognosis
Promoter Regions, Genetic
Survival Analysis
Treatment Outcome

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA016672NCI NIH HHSUnited StatesP30CA016672PubMed and NIHNIH RePORTER
P50 CA083639NCI NIH HHSUnited StatesP50CA083639PubMed and NIHNIH RePORTER
U24 CA143835NCI NIH HHSUnited StatesU24CA143835PubMed and NIHNIH RePORTER
U24CA143835NCI NIH HHSUnited StatesU24CA143835PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03976999Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal CancersResults

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections5

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in21990304Defining variations in survival of BRCA1 and BRCA2 mutation carriers.https://conductscience.org/library/papers/21990304PubMed
Comment in22024946Genetics: BRCA2 mutation offers response and survival advantages.https://conductscience.org/library/papers/22024946PubMed
Comment in22089419Genetics. BRCA inequality.https://conductscience.org/library/papers/22089419PubMed
Comment in22274678BRCA1 and BRCA2 mutations in ovarian cancer.https://conductscience.org/library/papers/22274678PubMed
Comment in22274679BRCA1 and BRCA2 mutations in ovarian cancer.https://conductscience.org/library/papers/22274679PubMed

Download CSV of comments and corrections

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111836499BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage.Nat Genet2002https://conductscience.org/library/papers/11836499PubMed
211786575Effect of BRCA mutations on the length of survival in epithelial ovarian tumors.J Clin Oncol2002https://conductscience.org/library/papers/11786575PubMed
38705994Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.Cancer Res1996https://conductscience.org/library/papers/8705994PubMed
416047333Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma.Cancer2005https://conductscience.org/library/papers/16047333PubMed
518087219BRCA1 regulates gamma-tubulin binding to centrosomes.Cancer Biol Ther2007https://conductscience.org/library/papers/18087219PubMed
615965487BRCA1 participates in DNA decatenation.Nat Struct Mol Biol2005https://conductscience.org/library/papers/15965487PubMed
78875917Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1.N Engl J Med1996https://conductscience.org/library/papers/8875917PubMed
812237281Cancer Incidence in BRCA1 mutation carriers.J Natl Cancer Inst2002https://conductscience.org/library/papers/12237281PubMed
918955455"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.J Clin Oncol2008https://conductscience.org/library/papers/18955455PubMed
1011239456Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.Mol Cell2001https://conductscience.org/library/papers/11239456PubMed
1116714056What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?Gynecol Oncol2006https://conductscience.org/library/papers/16714056PubMed
1217081976The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly.Cell2006https://conductscience.org/library/papers/17081976PubMed
1317525340Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response.Science2007https://conductscience.org/library/papers/17525340PubMed
1412470990The relationship between the roles of BRCA genes in DNA repair and cancer predisposition.Trends Mol Med2002https://conductscience.org/library/papers/12470990PubMed
1521720365Integrated genomic analyses of ovarian carcinoma.Nature2011https://conductscience.org/library/papers/21720365PubMed
1611832208Cancer susceptibility and the functions of BRCA1 and BRCA2.Cell2002https://conductscience.org/library/papers/11832208PubMed
1711239455BRCA2 is required for homology-directed repair of chromosomal breaks.Mol Cell2001https://conductscience.org/library/papers/11239455PubMed
1812712470Improved survival in women with BRCA-associated ovarian carcinoma.Cancer2003https://conductscience.org/library/papers/12712470PubMed
1917643121CCDC98 targets BRCA1 to DNA damage sites.Nat Struct Mol Biol2007https://conductscience.org/library/papers/17643121PubMed
2017643122CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response.Nat Struct Mol Biol2007https://conductscience.org/library/papers/17643122PubMed

See all 35 referencesDownload CSV of references

Cited by311

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 476 citations.

PMIDTitleJournalYearIn PapersSource
42940036Alternative Splicing of Homologous Recombination Genes Is Associated with Homologous Recombination Deficiency and Immunoregulatory Phenotypes in Breast Cancer.Biomedicines2026https://conductscience.org/library/papers/42940036PubMed
42820288Expanding the therapeutic scope of PARP inhibitors in breast cancer: current indications and future directions.J Clin Invest2026https://conductscience.org/library/papers/42820288PubMed
42778549Heterogeneity in cancer: molecular mechanisms and therapeutic strategies.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42778549PubMed
42394702Homologous recombination pathway alterations in basal-like breast cancer.Front Oncol2026https://conductscience.org/library/papers/42394702PubMed
42348196Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors.JAMA Oncol2026https://conductscience.org/library/papers/42348196PubMed
42296035SF3A3 in Liver Hepatocellular Carcinoma: Oncogenic Role and Prognostic Significance.Oncology2026https://conductscience.org/library/papers/42296035PubMed
42121636Association of BRCA Mutation Status with Clinical Outcomes in High-Grade Serous Ovarian Cancer.Healthcare (Basel)2026https://conductscience.org/library/papers/42121636PubMed
41724111Quantifying rate-limiting genetic variation in breast and ovarian tumourigenesis.EBioMedicine2026https://conductscience.org/library/papers/41724111PubMed
41711981
Evaluating tumor chemosensitivity: a head-to-head comparison of the prognostic value of KELIM (modeled CA125 elimination rate constant K) and RECIST 1.1 (radiological response valuation criteria in solid tumors) in ovarian cancer.
Arch Gynecol Obstet2026https://conductscience.org/library/papers/41711981PubMed
41646477A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer.ESMO Gastrointest Oncol2025https://conductscience.org/library/papers/41646477PubMed
41567614Impact of carboplatin desensitization therapy on progression-free survival in gynecologic cancers.Gynecol Oncol Rep2026https://conductscience.org/library/papers/41567614PubMed
41354605Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations.Eur Urol Focus2026https://conductscience.org/library/papers/41354605PubMed
41299328CLIC3 emerges as a novel prognostic biomarker and therapeutic target in triple-negative breast cancer through integrated multi-omics analysis.BMC Cancer2025https://conductscience.org/library/papers/41299328PubMed
41264162Clinical and molecular determinants of response to maintenance olaparib for primary and recurrent epithelial ovarian carcinoma.Clin Transl Oncol2026https://conductscience.org/library/papers/41264162PubMed
41256539An Interpretable Deep Learning Framework for Biomarker Discovery in Complex Disease Survival Outcomes.bioRxiv2025https://conductscience.org/library/papers/41256539PubMed
41093344Prognostic significance of tumour-infiltrating T lymphocytes in ovarian cancer: a protocol for systematic review and meta-analysis.BMJ Open2025https://conductscience.org/library/papers/41093344PubMed
41068641Germline and somatic mutational variants of Tunisian high grade serous ovarian cancer identified by next-generation sequencing.BMC Cancer2025https://conductscience.org/library/papers/41068641PubMed
40979227Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship.Ther Adv Med Oncol2025https://conductscience.org/library/papers/40979227PubMed
40948768Panoramic view of MDH1: driving cancer progression and shaping the tumor immune microenvironment.Front Immunol2025https://conductscience.org/library/papers/40948768PubMed
40923759Moss BRCA2 lacking the canonical DNA-binding domain promotes homologous recombination and binds to DNA.Nucleic Acids Res2025https://conductscience.org/library/papers/40923759PubMed

See all 311 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL3602PubTator's text mininghttps://conductscience.org/library/genes/602NCBI Gene
BLM641PubTator's text mininghttps://conductscience.org/library/genes/641NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
RAD515888PubTator's text mininghttps://conductscience.org/library/genes/5888NCBI Gene
TP638626PubTator's text mininghttps://conductscience.org/library/genes/8626NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21990299

GET https://conductscience.org/api/papers/v1/21990299/references?page=2